IL23717A - Novel quinazolinones for treating coccidiosis - Google Patents

Novel quinazolinones for treating coccidiosis

Info

Publication number
IL23717A
IL23717A IL23717A IL2371765A IL23717A IL 23717 A IL23717 A IL 23717A IL 23717 A IL23717 A IL 23717A IL 2371765 A IL2371765 A IL 2371765A IL 23717 A IL23717 A IL 23717A
Authority
IL
Israel
Prior art keywords
treating coccidiosis
quinazolinones
novel
novel quinazolinones
coccidiosis
Prior art date
Application number
IL23717A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL23717A publication Critical patent/IL23717A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL23717A 1964-07-20 1965-06-11 Novel quinazolinones for treating coccidiosis IL23717A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US383910A US3320124A (en) 1964-07-20 1964-07-20 Method for treating coccidiosis with quinazolinones

Publications (1)

Publication Number Publication Date
IL23717A true IL23717A (en) 1971-01-28

Family

ID=23515259

Family Applications (1)

Application Number Title Priority Date Filing Date
IL23717A IL23717A (en) 1964-07-20 1965-06-11 Novel quinazolinones for treating coccidiosis

Country Status (7)

Country Link
US (1) US3320124A (es)
BR (1) BR6571429D0 (es)
DE (1) DE1545551B2 (es)
ES (1) ES315612A1 (es)
FR (1) FR1550956A (es)
GB (1) GB1087015A (es)
IL (1) IL23717A (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2339402A1 (fr) * 1976-01-29 1977-08-26 Roussel Uclaf Nouvelle quinazolinone et ses sels, leurs procede de preparation et leur application comme medicament
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
FR2467630A1 (fr) * 1979-10-23 1981-04-30 Roussel Uclaf Nouvelles resines echangeuses d'ions du type acide, leur procede de preparation et leur application comme medicament
US4364928A (en) * 1979-10-23 1982-12-21 Roussel-Uclaf Novel salts of ion exchange resins of the acid type
US4725599A (en) * 1986-09-08 1988-02-16 Pfizer Inc. Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial agents
US4797486A (en) * 1986-09-08 1989-01-10 Pfizer Inc. Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents
US5314700A (en) * 1991-01-28 1994-05-24 Ethyl Corporation Poultry feed component
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
IL112125A (en) * 1994-12-22 1998-02-08 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
US6090814A (en) * 1995-08-15 2000-07-18 Agricultural Research Organization Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
EP0936910B1 (en) * 1996-08-30 2002-07-24 Agricultural Research Organization, Ministry Of Agriculture, State Of Israel Intracoronary stents containing quinazolinone derivatives
US6028075A (en) 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
IL132848A (en) * 1997-05-23 2004-08-31 Israel State Preparation for the treatment of fetal cirrhosis
US6562829B1 (en) 1997-05-23 2003-05-13 Hadasit Medical Research Services & Development Co., Ltd. Treatment of hepatic cirrhosis
US6159488A (en) * 1997-08-14 2000-12-12 Agricultural Research Org. Ministry Of Agriculture (Gov.) Intracoronary stents containing quinazolinone derivatives
CA2340176A1 (en) * 1998-08-13 2000-02-24 Hadasit Medical Research Services And Development Company Ltd. Inhibition of pathogenic processes related to tissue trauma
US7230000B1 (en) * 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
IL143366A0 (en) * 2001-05-24 2002-04-21 Harasit Medical Res Services & Treatment of renal fibrosis
US6753428B2 (en) * 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
IL147416A (en) * 2001-12-31 2008-11-26 Israel State Combined modalities for improved cancer treatment
US7009049B2 (en) * 2002-02-15 2006-03-07 Cytokinetics, Inc. Syntheses of quinazolinones
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
EP1503993A4 (en) * 2002-05-09 2006-05-03 Cytokinetics Inc COMPOUNDS, METHODS AND COMPOSITIONS
EP1553931A4 (en) 2002-05-09 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2003103575A2 (en) * 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
JP2005538062A (ja) * 2002-06-14 2005-12-15 サイトキネティクス・インコーポレーテッド 化合物、組成物、および方法
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
WO2004018058A2 (en) * 2002-08-21 2004-03-04 Cytokinetics, Inc. Compounds, compositions, and methods
US7557115B2 (en) * 2002-09-30 2009-07-07 Cytokinetics, Inc. Compounds, compositions, and methods
US20050197327A1 (en) * 2003-11-03 2005-09-08 Gustave Bergnes Compounds, compositions, and methods
JP2007510660A (ja) * 2003-11-07 2007-04-26 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
WO2005061460A1 (en) * 2003-12-08 2005-07-07 Cytokinetics, Inc. Compounds, compositions, and methods
CN1304391C (zh) * 2004-02-06 2007-03-14 上海因诺生化科技有限公司 氢溴酸常山酮的制备方法
CA2600046A1 (en) * 2005-02-23 2006-08-31 Collgard Biopharmaceuticals Ltd. Pharmaceutical compositions of the isolated d- enantiomer of the quinazolinone derivative halofuginone
AU2007238816B2 (en) * 2006-04-10 2012-12-06 President And Fellows Of Harvard College Methods for modulating formation and progression of cellulite
EP2099454A4 (en) * 2006-11-17 2010-11-10 Abbott Lab AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
WO2008087650A2 (en) 2007-01-21 2008-07-24 Agricultural Research Organization Composition and method for treating or preventing skeletal muscle fibrosis
US20090123389A1 (en) * 2007-08-15 2009-05-14 Malcolm Whitman Methods for modulating Th17 cell development in the treatment and prevention of cellulite
US20110212100A1 (en) * 2007-08-15 2011-09-01 Tracy Keller Methods for modulating development and expansion of il-17 expressing cells
FR2922451A1 (fr) * 2007-10-23 2009-04-24 Windgan Trading Traitement des retrecissements de l'uretre
US9284297B2 (en) * 2008-08-11 2016-03-15 President And Fellows Of Harvard College Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
US8357692B2 (en) 2010-06-20 2013-01-22 Washington University Methods of treatment of bone degenerative diseases
AU2013207796B2 (en) 2012-01-13 2017-04-27 President And Fellows Of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
WO2019237125A1 (en) 2018-06-08 2019-12-12 The General Hospital Corporation Inhibitors of prolyl-trna-synthetase
CN111233831A (zh) * 2020-03-18 2020-06-05 郑州市华农兽药研究院 常山铜琥珀酸单酯及其制备方法与用途
CN112409272A (zh) * 2020-11-26 2021-02-26 河北美荷药业有限公司 一种6-氯-7-溴-4（3h）-喹唑啉酮的制备方法和应用

Also Published As

Publication number Publication date
BR6571429D0 (pt) 1973-08-14
DE1545551A1 (de) 1969-10-16
GB1087015A (en) 1967-10-11
FR1550956A (es) 1968-12-27
DE1545551B2 (de) 1976-12-23
US3320124A (en) 1967-05-16
ES315612A1 (es) 1966-07-01

Similar Documents

Publication Publication Date Title
IL23717A (en) Novel quinazolinones for treating coccidiosis
IL24435A (en) Photoelectrosolography
IL22865A (en) Transfer-material
GB1201359A (en) Audio-transducer
IL23443A (en) Phenylalkylaminoguanidines
IL31176A (en) Dibenzocycloheptatriene compounds
MY7100179A (en) Ortho-aminoarylketimines
GB1122891A (en) Ophthalmometer
GB1122814A (en) Semiconductor controlled rectifier
IL23210A (en) 25-aza-cholestatrienes
MY6600143A (en) Substituted imidazolidines
IL23858A (en) Tetrahydroazepinoindoles
MY6900080A (en) Novel des-a-steroids
IL23555A (en) Aminoquinoline derivatives
IL24361A (en) N6-2-hydroxyethyl tubericidin
IL24502A (en) Pregnan-21-ol-esters
IL23724A (en) Epoxidation process
IE28545L (en) Quinazoline 3-oxides
GB1042018A (en) Tackmeter
IE27672L (en) Treating wort
CA699170A (en) Treating coke
IE27854L (en) Quinazolinone derivatives
IE27853L (en) Quinazolinone derivatives
IE28103L (en) Sulphanilamido pyrimidines
IE28470L (en) Pyrimidine compounds